Skip to main content
SpringerLink
Log in

Obesity and Therapeutic Approaches to Weight Loss

  • Chapter
  • First Online:
Comprehensive Cardiovascular Medicine in the Primary Care Setting

Part of the book series: Contemporary Cardiology ((CONCARD))

Abstract

Weight gain and obesity are becoming the most significant chronic public health conditions of our generation, impacting the well-being, productivity, longevity, and economics of our society. Over two-thirds of US adults are overweight or obese, leading to an increase in the incidence of type 2 diabetes, obstructive sleep apnea, cardiovascular disease, and some types of cancer. The etiology of obesity is multifactorial, brought about by an interaction between predisposing genetic and metabolic factors and a rapidly changing environment, one that favors excessive caloric intake while at the same time reducing opportunities to engage in a physically active lifestyle. Assessment of obesity should be performed in the primary care setting. Treatment includes lifestyle management and consideration of pharmacotherapy and bariatric surgery depending upon the severity of obesity and associated comorbid conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ng M, Flemming T, Robinson M, Thompson B, Margono C, Mullany E, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766–81.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005;352(11):1138–45.

    Article  CAS  PubMed  Google Scholar 

  3. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014;311(8):806–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 2007;298:2028–37.

    Article  CAS  PubMed  Google Scholar 

  5. Alley DE, Chang VW. The changing relationship of obesity and disability, 1988–2004. JAMA. 2007;298:2020–7.

    Article  CAS  PubMed  Google Scholar 

  6. Srikanthan P, Kartamangla AS. Muscle mass index as a predictor of longevity in older adults. Am J Med. 2014;127:547–53.

    Article  PubMed  PubMed Central  Google Scholar 

  7. DeCaria JE, Sharp C, Petrella RJ. Scoping review report: obesity in older adults. Intern J Obesity. 2012;36:1141–50.

    Article  CAS  Google Scholar 

  8. Rillamas-Sun E, LaCroix AZ, Waring ME, Kroenke CH, LaMonte MJ, Vitolins MZ, et al. Obesity and late-age survival without major disease or disability in older women. JAMA Intern Med. 2014;174(1):98–106.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Garvey WT, Garber AJ, Mechanick JI, Bray GA, Dagogo-Jack S, Einhorn D, et al. American association of clinical endocrinologists and American college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. Endocr Pract. 2014;20(9):977–89.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr Pract. 2016;22(Supplement 3):1–202.

    Article  PubMed  Google Scholar 

  11. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2013;129(25 Supplement 2):S102–38.

    PubMed  PubMed Central  Google Scholar 

  12. Bays HE, Seger JC, Primack C, McCarthy W, Long J, Schmidt SL, Daniel S, Wendt J, Horn DB, Westman EC. Obesity Algorithm, presented by the Obesity Medicine Association. www.obesityalgorithm.org. (2016–2017). Accessed 6 Jan 2017.

  13. Moyer VA, on behalf of the U.S. Preventative Services Task Force. Screening for and management of obesity in adults: U.S. Preventative Services Task Force Recommendation Statement. Ann Intern Med. 2012;157:373–8.

    PubMed  Google Scholar 

  14. LeFevre ML. U.S. Preventive Services Task Force. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2014;161(8):587–93.

    Article  PubMed  Google Scholar 

  15. National Heart, Lung, and Blood Institute (NHLBI). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The evidence report. Obes Res. 1998;6(Suppl 2):51S–210S.

    Google Scholar 

  16. National Heart, Lung, and Blood Institute (NHLBI) and North American Association for the Study of Obesity (NAASO). Practical guide to the identification, evaluation, and treatment of overweight and obesity in adults. Bethesda: National Institutes of Health. NIH Publication number 00–4084, Oct 2000.

    Google Scholar 

  17. Stefan N, Haring HU, Hu FB, Schuler MB. Metabolically healthy-obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013;1:152–62.

    Article  PubMed  Google Scholar 

  18. Seo MH, Rhee EJ. Metabolic and cardiovascular implications of a metabolically healthy obesity phenotype. Endocrinol Metab. 2014;29:427–34.

    Article  Google Scholar 

  19. Camhi SM, Katzmarzyk PT. Differences I body composition between metabolically healthy obese and metabolically abnormal obese adults. Intern J Obesity. 2014;38:1142–5.

    Article  CAS  Google Scholar 

  20. Rey-Lopez JP, de Rezende LF, Pastor-Valero M, Tess BH. The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used. Obes Rev. 2014;15:781–90.

    Article  CAS  PubMed  Google Scholar 

  21. van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, Doiron D, Fischer K, Foco L, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocinol Disord. 2014;14:9. http;//biomedcentral.com/1472-6823/14/9

    Article  Google Scholar 

  22. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering. Prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med. 2008;168(15):1617–24.

    Article  PubMed  Google Scholar 

  23. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008;168:1609–16.

    Article  PubMed  Google Scholar 

  24. Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med. 2013;159:758–69.

    Article  PubMed  Google Scholar 

  25. Bell JA, Hamer M, Sabia S, Singh-Manoux A, Batty GD, Kivimaki M. The natural course of healthy obesity over 20 years. J Am Coll Cardiol. 2015;65(1):101–2.

    Article  PubMed  Google Scholar 

  26. Eckel N, Meidtner K, Kalle-Uhlmann T, Stefan N, Schulze MB. Metabolically healthy obesity and cardiovascular events: a systematic review and meta-analysis. Prev Card. 2016;23(9):956–66.

    Article  Google Scholar 

  27. Hwang Y-C, Hayashi T, Fujimoto WY, Kahn SE, Leonetti DL, McNeely MJ, et al. Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype. Intern J Obesity. 2015;39:1365–70.

    Article  CAS  Google Scholar 

  28. Roberson LL, Aneni EC, Maziak W, Agatston A, Feldman T, Rouseff M, et al. Beyond BMI: the “metabolically healthy obese” phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality – a systematic review. BMC Public Health. 2014;14(14). http://www.biomedcentral.com/1471-2458/14/14

  29. Jae SY, Franklin B, Choi YH, Fernhall B. Metabolically healthy obesity and carotid intima-media thickness: effects of cardiorespiratory fitness. Mayo Clin Proc. 2015;90(9):1217–24.

    Article  PubMed  Google Scholar 

  30. Daniel S, Soleymani T, Garvey WT. A complications-based clinical staging of obesity to guide treatment modality and intensity. Curr Opin Endocrinol Diabetes Obes. 2013;20:377–88.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for Comprehensive Medical Care of Patients with Obesity – Executive Summary. Endocrine Practice. 2016; https://doi.org/10.4158/EP161365.GL.

    Article  PubMed  Google Scholar 

  32. Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Intern J Obesity. 2009;33:289–95.

    Article  CAS  Google Scholar 

  33. Kuk JL, Ardern CI, Church TS, Sharma AM, Padwal R, Sul X, et al. Edmonton obesity staging system: association with weight history and mortality risk. Appl Physiol Nutr Metab. 2011;36:570–6.

    Article  PubMed  Google Scholar 

  34. Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ. 2011; https://doi.org/10.1503/cmaj110387.

  35. Klein S, Burke LE, Bray GA, Blair S, Allison DB, Pi-Sunyer X, et al. Clinical implications of obesity with specific focus on cardiovascular disease. A statement for professionals from the American Heart Association Council on nutrition, physical activity, and metabolism. Circulation. 2004;110:2952–67.

    Article  PubMed  Google Scholar 

  36. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer X, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. An update of the 1997 American Heart Association scientific statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism. Circulation. 2006;113:898–918.

    Article  PubMed  Google Scholar 

  37. Harsha DW, Bray GA. Weight loss and blood pressure control (pro). Hypertension. 2008;51:1420–5.

    Article  CAS  PubMed  Google Scholar 

  38. Burke GL, Bertoni AG, Shea S, Tracy R, Watson KE, Blumenthal RS, et al. The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease. The multi-ethnic study of atherosclerosis. Arch Intern Med. 2008;168:928–35.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Wang TJ, Parise H, Levy D, D’Agostino RB Sr, Wolf PA, Vasan RS, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292:2471–7.

    Article  CAS  PubMed  Google Scholar 

  40. Kenchaiah S, Evans JC, Levy D, Wilson PWR, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305–13.

    Article  PubMed  Google Scholar 

  41. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L. NEDCOM, the Netherlands Epidemiology and Demography Compression of Morbidity Research Group. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med. 2003;138:24–32.

    Article  PubMed  Google Scholar 

  42. Madala MC, Franklin BA, Chen AY, Berman AD, Roe MT, Peterson ED, et al. CRUSADE Investigators. Obesity and age of first non-ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2008;52:979–85.

    Article  PubMed  Google Scholar 

  43. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:16–8.

    Article  CAS  Google Scholar 

  44. Zhu SK, Wang ZM, Heshka S, Heo M, Faith MS, Heymsfield SB. Waist circumference and obesity-associated risk factors among whites in the third national health and nutrition examination survey: clinical action thresholds. Am J Clin Nutr. 2002;76:743–9.

    Article  CAS  PubMed  Google Scholar 

  45. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004;79:379–84.

    Article  CAS  PubMed  Google Scholar 

  46. Alberti KGMM, Eckel RH, Grundy SM, Zimmer PZ, Cleeman JI, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5.

    Article  CAS  PubMed  Google Scholar 

  47. Kushner RF, Ryan DH. Assessment and lifestyle management of patients with obesity. Clinical recommendations from systematic reviews. JAMA. 2014;312(9):943–52.

    Article  CAS  PubMed  Google Scholar 

  48. Franz MJ, VanWormer JJ, Crain AL, et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum of 1-year follow-up. J Am Diet Assoc. 2007;107:1755–67.

    Article  PubMed  Google Scholar 

  49. Carvajal R, Wadden TA, Tsai AG, Peck K, Moran CH. Managing obesity in primary care practice: a narrative review. Ann N Y Acad Sci. 2013;1281:191–206.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Wadden TA, Butryn ML, Hong PS, Tsai AG. Behavioral treatment of obesity in patients encountered in primary care settings. A systematic review. JAMA. 2014;312(17):1779–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Fitzpatrick SL, Wischenka D, Appelhans BM, Pbert L, Wang M, Wilson DK, et al. An evidence-based guide for obesity treatment in primary care. Am J Med. 2016;129:115e1–7.

    Article  Google Scholar 

  52. Bowerman S. The role of meal replacements in weight control. In: Bessesen DH, Kushner R, editors. Evaluation & management of obesity. Philadelphia: Hanley & Belfus, Inc; 2002. p. 53–8.

    Google Scholar 

  53. Heymsfield SB, van Mierlo CAJ, van der Knaap HCM, Frier HI. Weight management using meal replacement strategy: meta and pooling analysis from six studies. Int J Obes. 2003;27:537–49.

    Article  CAS  Google Scholar 

  54. The Look AHEAD, Research G. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes. One year results of the LOOK AHEAD trial. Diab Care. 2007;30:1374–83.

    Article  Google Scholar 

  55. Johnson BC, Kanters S, Bandayrel K, Wu P, Naji F, Siemieniuk RA, et al. Comparison of weight loss among named diet programs in overweight and obese adults. A meta-analysis. JAMA. 2014;312(9):923–33.

    Article  CAS  Google Scholar 

  56. Anderson JW, Konz EC, Frederich RC, Wood CL. Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr. 2001;74:579–84.

    Article  CAS  PubMed  Google Scholar 

  57. 2008 Physical Activity Guidelines for Americans. www.health.gov/paguidelines

  58. Dunn AL, Marcus BH, Kampert JB, Garcia ME, Kohl HW 3rd, Blair SN. Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness. A randomized trial. JAMA. 1999;281:327–34.

    Article  CAS  PubMed  Google Scholar 

  59. Anderson RE, Wadden TA, Bartlett SJ, Zemel B, Verde TJ, Franckowiak SC. Effects of lifestyle activity vs structured aerobic exercise in obese women. A randomized trial. JAMA. 1999;281:335–40.

    Article  Google Scholar 

  60. Jakicic JM, Clark K, Coleman E, Donnelly JE, Foreyt J, Melanson E, Volek J, et al. Appropriate intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc. 2001;33:2145–56.

    Article  CAS  PubMed  Google Scholar 

  61. Miller WR, Rollnick S, editors. Motivational interviewing. Preparing people for change. 2nd ed. New York: The Guilford Press; 2002.

    Google Scholar 

  62. Prochasea JO, DiClimente CC. Toward a comprehensive model of change. In: Miller WR, editor. Treating addictive behaviors. New York: Plenum; 1986. p. 3–27.

    Chapter  Google Scholar 

  63. Wadden TA, Crerand CE, Brock J. Behavioral treatment of obesity. Psychiatr Clin N Am. 2005;28:151–70.

    Article  Google Scholar 

  64. Foreyt JP, Poston WSC. What is the role of cognitive-behavior therapy in patient management? Obes Res. 1998;6(Suppl 1):18S–22S.

    Article  PubMed  Google Scholar 

  65. Wadden TA, Foster GD. Behavioral treatment of obesity. Med Clin North Am. 2000;84:441–62.

    Article  CAS  PubMed  Google Scholar 

  66. Hollis JF, Gullion CM, Stevens VJ, et al. Weight loss during the intensive intervention phase of the weight-loss maintenance trial. Am J Prev Med. 2008;35:118–26.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Wadden TA, Berkowitz RI, Sarwer DB, Prus-Wisniewski R, Steinberg C. Benefits of lifestyle modification in the pharmacologic treatment of obesity. A randomized trial. Arch Intern Med. 2001;161:218–27.

    Article  CAS  PubMed  Google Scholar 

  68. Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U, et al. Pharmacological management of obesity: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(2):342–62.

    Article  CAS  PubMed  Google Scholar 

  69. Allison DB, Gadde KM, Garvey WT, Peterson CA, Schwiers ML, Najarian T, et al. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity. 2012;20(2):330–42.

    Article  CAS  PubMed  Google Scholar 

  70. Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML, et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet. 2011;377:1341–52.

    Article  CAS  PubMed  Google Scholar 

  71. Garvey WT, Ryan DH, Look M, Gadde KM, Allison DB, Peterson CA, et al. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr. 2012;95:297–308.

    Article  CAS  PubMed  Google Scholar 

  72. Smith SR, Weissman NJ, Anderson CM, Sanchez M, Chuang E, Stubbe S, et al. Behavioral Modification and Lorcaserin for Overweight and Obesity Management (BLOOM) Study Group. Multicenter, placebo-controlled trial of lorcaserin for weight management. New Engl J Med. 2010;363:245–56.

    Article  CAS  PubMed  Google Scholar 

  73. Fidler MC, Sanchez M, Raether B, Weissman NJ, Smith SR, Shanahan WR, et al. BLOSSOM Clinical Trial Group. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial. J Clin Endocrinol Metab. 2011;96(10):3067–77.

    Article  CAS  PubMed  Google Scholar 

  74. Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, et al. COR-I Study Group. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2010;376(9741):595–605.

    Article  CAS  PubMed  Google Scholar 

  75. Apovian CM, Aronne L, Rubino D, Still C, Wyatt H, Burns C, et al. COR-II Study Group. A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity. 2013;21(5):935–43.

    Article  CAS  PubMed  Google Scholar 

  76. Wadden TA, Foreyt JP, Foster GD, Hill JO, Klein S, O’Neil PM, et al. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity. 2011;19(1):110–20.

    Article  CAS  PubMed  Google Scholar 

  77. Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, et al. SCALE obesity and prediabetes NN8022-1839 Study Group. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New Engl J Med. 2015;373:11–22.

    Article  PubMed  CAS  Google Scholar 

  78. Davies MJ, Bergenstal R, Bode B, Kushner RF, Lewin A, Skjøth TV, et al. Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE diabetes randomized clinical trial. JAMA. 2015;314(7):687–99.

    Article  CAS  PubMed  Google Scholar 

  79. Wadden TA, Hollander P, Klein S, Niswender K, Woo V, Hale PM, et al. NN8022-1923 Investigators. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study. Int J Obesity. 2013;37(11):1443–51.

    Article  CAS  Google Scholar 

  80. Lucas KH, Kaplan-Machlis B. Orlistat—a novel weight loss therapy. Ann Pharmacother. 2001;35:314–28.

    Article  CAS  PubMed  Google Scholar 

  81. Rucker D, Padwal R, Li SK, (ADD 3 AUTHORS), et al. Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ. 2007;335:1194–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L. XENical in the prevention of diabetes in Obese Subjects (XENDOS) Study. Diabetes Care. 2004;27:155–61.

    Article  CAS  PubMed  Google Scholar 

  83. Cavaliere H, Floriano I, Medeiros-Neto G. Gastrointestinal side effects of orlistat may be prevented by concomitant prescription of natural fibers (psyllium mucilloid). Int J Obes. 2001;25:1095–9.

    Article  CAS  Google Scholar 

  84. Varela E, Nguyen NT. Laparoscopic sleeve gastrectomy leads the U.S. utilization of bariatric surgery at academic medical centers. SOARD. 2015;11:987–90.

    Google Scholar 

  85. Buchwald H, Avidor Y, Braunwald E, Jenson MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.

    Article  CAS  PubMed  Google Scholar 

  86. Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Livingston EH, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142:547–59.

    Article  PubMed  Google Scholar 

  87. O’Brien PE, McPhail T, Chaston TB, Dixon JB. Systematic review of medium-term weight loss after bariatric operations. Obes Surg. 2005;16:1032–40.

    Article  Google Scholar 

  88. Padwal R, Klarenbach S, Wiebe N, Birch D, Karmali S, Manns B, et al. Bariatric surgery: a systematic review and network meta-analysis of randomized trials. Obes Rev. 2011;12:602–21.

    Article  CAS  PubMed  Google Scholar 

  89. Dixon J, Straznicky NE, Lambert EA, Schlaich MP, Lambert GW. Laparoscopic adjustable gastric banding and other devices for the management of obesity. Circulation. 2012;126:774–85.

    Article  PubMed  Google Scholar 

  90. Smith BR, Schauer P, Nguyen NT. Surgical approaches to the treatment of obesity: bariatric surgery. Med Clinics North Am. 2011;95:1009–30.

    Article  Google Scholar 

  91. Zhou X, Yu J, Li L, Gloy VL, Nordmann A, Tiboni M, et al. Effects of bariatric surgery on mortality, cardiovascular events, and cancer outcomes in obese patients: Systematic review and meta-analysis. Obes Surg. 2016;26(11):2590–601. online

    Article  PubMed  Google Scholar 

  92. Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg. 2011;253(3):484–7.

    Article  PubMed  Google Scholar 

  93. Vetter ML, Cardillo S, Richels MR, Iqbal N. Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med. 2011;150:94–103.

    Article  Google Scholar 

  94. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56.

    Article  PubMed  Google Scholar 

  95. Dixon JB, le Roux CW, Rubino F, Zimmet P. Bariatric surgery for type 2 diabetes. Lancet. 2012;379:2300–11.

    Article  PubMed  Google Scholar 

  96. Courcoulas AP, Belle SH, Neiberg RH, Pierson SK, Eagleton JK, Kalarchian MA, et al. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment. A randomized clinical trial. JAMA Surg. 2015;150:931–40.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  97. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, et al. Bariatric surgery versus intensive medical therapy for diabetes—3 year outcome. N Engl J Med. 2014;370(21):2002–13.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  98. Arterburn D, Bogart A, Coleman KJ, Haneuse S, Selby JV, Sherwood NE, et al. Comparative effectiveness of bariatric surgery vs. nonsurgical treatment of type 2 diabetes among severely obese adults. Obes Res Clin Pract. 2013;7:e258–68.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Madsbad S, Dirksen C, Holst JJ. Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery. Lancet Diabetes Endocrinol. 2014;2:152–64.

    Article  CAS  PubMed  Google Scholar 

  100. Mechanick JI, Youdim A, Jones DB, Garvey WT, Daniel L, Hurley M, et al. Clinical practice guidelines for the perioperative nutritional, metabolic and nonsurgical support of the bariatric patient – 2013 update. Cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic and Bariatric Surgery. Obesity. 2013;21(Suppl):S1–S27.

    Article  CAS  PubMed  Google Scholar 

  101. Kushner RF. Micronutrient deficiencies and bariatric surgery. Curr Opin Endocrinol Diabetes. 2006;13:405–11.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

    Robert F. Kushner

Authors
  1. Robert F. Kushner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert F. Kushner .

Editor information

Editors and Affiliations

  1. Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Peter P. Toth

  2. Cardiovascular Division, Harvard Medical School Brigham & Women’s Hospital, Boston, MA, USA

    Christopher P. Cannon

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kushner, R.F. (2019). Obesity and Therapeutic Approaches to Weight Loss. In: Toth, P., Cannon, C. (eds) Comprehensive Cardiovascular Medicine in the Primary Care Setting. Contemporary Cardiology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-97622-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-97622-8_4

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-97621-1

  • Online ISBN: 978-3-319-97622-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation